Bio-Rad Laboratories, Inc.Class A (BIO) — Analysis Summary
Bio-Rad Laboratories, Inc.Class A (BIO) has a market cap of $8.36B with year-over-year revenue growth of +0.7%. Net margin stands at 29.4%. The stock trades at a P/E ratio of 49.5.
Key Takeaways
- Revenue changed +0.7% year-over-year
- Net margin of 29.4%
- P/E ratio of 49.5
Compared to other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector, BIO posted revenue growth of +0.7% and trades at a P/E of 49.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.